A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia

Completed · Phase 2 · Has a placebo group

Conditions studied: Gout, Hyperuricemia

In brief

The aim of this 12-week randomized multicenter double-blind parallel group placebo-controlled dose finding study is to assess the efficacy and safety of three different doses of LC350189 in subjects with hyperuricemia and a diagnosis of gout.

Key facts

Study ID

NCT03934099

Run by

LG Chem

People needed

156

Starts

2019-12-02

Expected to finish

2021-05-17

Last updated by the study team

2025-12-03

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects or the subject's legally acceptable representatives who sign a written informed consent form prior to the initiation of any study procedures.
• Subjects with hyperuricemia and a history or presence of gout per American College of Rheumatology (ACR) criteria.

You may not qualify if…

• Subjects with secondary hyperuricemia (e.g., due to myeloproliferative disorder, or organ transplant).
• Subjects experiencing an active acute gout attack within 3 weeks prior to screening (Visit 1).

Where it is running

• Synexus Clinical Research — Birmingham, Alabama, United States
• Synexus Clinical Research — Chandler, Arizona, United States
• Synexus Clinical Research — Mesa, Arizona, United States
• Synexus Clinical Research — Tucson, Arizona, United States
• Preferred Research Partner — Little Rock, Arkansas, United States
• Health Awareness Inc — Jupiter, Florida, United States
• Meridien Research — Maitland, Florida, United States
• Miami Dade Medical Research Institute — Miami, Florida, United States
• Meridien Research — St. Petersburg, Florida, United States
• Clinical Research Trials of Florida, Inc — Tampa, Florida, United States
• Avita Clinical Trials — Tampa, Florida, United States
• IACT Health — Columbus, Georgia, United States
• Synexus Clinical Research — Chicago, Illinois, United States
• Synexus Clinical Research — Richfield, Minnesota, United States
• Olive Branch Family Medical Cente — Olive Branch, Mississippi, United States
• Synexus Clinical Research — St Louis, Missouri, United States
• Quality Clinical Research — Omaha, Nebraska, United States
• Synexus Clinical Research — Omaha, Nebraska, United States
• Synexus Clinical Research — Henderson, Nevada, United States
• OnSite Clinical Solutions — Charlotte, North Carolina, United States
• OnSite Clinical Solutions — Charlotte, North Carolina, United States
• Synexus Clinical Research — Akron, Ohio, United States
• Synexus Clinical Research — Cincinnati, Ohio, United States
• Synexus Clinical Research — Columbus, Ohio, United States
• Paramount Medical Research and Consulting — Middleburg Heights, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.